Treatment of cancers using anti-NKG2A agents

• 收藏
• 分享

专利权人:

Innate Pharma

发明人:

Andre, Pascale,Blery, Mathieu,Soulas, Caroline,Wagtmann, Nicolai

申请号：

AU2015334886

公开号：

AU2015334886A1

申请日:

2015.10.23

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

The present disclosure relates to HLA-E as a tumor escape mechanism in head and neck cancer. The disclosure relates to methods for the treatment of head and neck cancer, notably HLA-E expressing head and neck squamous cell carcinoma, using antibodies that specifically bind and inhibit human NKG2A.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/